CRISPR-based electrochemical biosensors: an alternative for point-of-care diagnostics?

Dagwin Wachholz Junior1, Lauro Tatsuo Kubota1

  • 1Department of Analytical Chemistry, Institute of Chemistry, University of Campinas (UNICAMP), 13083-970, Brazil; National Institute of Science and Technology in Bioanalytic (INCTBio), Brazil.

Talanta
|July 5, 2024
PubMed
Summary

CRISPR technology combined with electrochemical sensors offers a powerful new approach for rapid, precise point-of-care diagnostics. This review explores their potential to revolutionize disease detection and healthcare accessibility.